5:44 PM
 | 
Feb 26, 2013
 |  BC Extra  |  Company News

ODAC to discuss Aveo, Delcath cancer compounds

FDA's Oncologic Drugs Advisory Committee will meet on May 2 to discuss NDAs for two cancer compounds from Aveo Pharmaceuticals Inc. (NASDAQ:AVEO) and Delcath Systems Inc. (NASDAQ:DCTH). The committee will discuss Aveo's...

Read the full 150 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >